Elan Pharmaceuticals. Elan Pharmaceuticals, a US. based mutinational pharmaceutical company, is evaluating an export sale of its cholestorof reduction drog with a prospective indonesian distributor. The purchase would be for 1,640 milion Indonesian rupiah (Rp), which at the current spot exchange rate of Rp9.50015, translates into $172.631.58. Although not a big sale by compary standards, company policy dictates that sales must be settled for at least a minimum gross margin, in this case, a cash settioment of $166,000, The carrent 90 -day fonward rafe is Rp9,94015. Although this rate appeared unatractive, Elan had to contact several major bariss before even finding a forward quote on the rupiah, The consensus of currency forecasters at the moment, however, is that the ruplah will continue to strengthen, possibly rising to Rp 10,220/5 over the coming 90 to 120 days. Anolyze the prospective saie and make a hedping recommendation. How much in U.S. dollars will Elan receive in 90 days without a hedge if the expected spot rate in 90 days is assumed to be Rip9.500/5? (Round to the nearest cent)